Current Assets Cambio Fecha
AbbVie USD 33.22B 4.37B 2023-09
Acadia Pharmaceuticals USD 616.12M 116.96M 2023-12
ALKERMES USD 1.46B 67.43M 2023-09
Alnylam Pharmaceuticals USD 2.98B 2.76M 2023-12
Amarin USD 717.51M 11.02M 2023-09
Amgen USD 30.33B 18.14B 2023-12
Baxter International USD 9.6B 2.43B 2023-12
Biogen USD 6.86B 1.59B 2023-12
BioMarin Pharmaceutical USD 2.96B 780K 2023-12
Bluebird Bio USD 247.08M 40.9M 2023-09
Bristol-Myers Squibb USD 27.63B 442M 2023-09
Eli Lilly USD 23.01B 1.68B 2023-09
Fujifilm JPY 1.74T 51.31B 2023-09
Gilead Sciences USD 16.45B 474M 2023-12
Ironwood Pharmaceuticals USD 233.29M 20.32M 2023-12
Merck USD 31.95B 1.98B 2023-09
Myriad Genetics USD 313.6M 48.2M 2023-12
Pacira USD 509.99M 62.74M 2023-12
Perrigo USD 2.77B 7.7M 2023-09
Pfizer USD 74.01B 665M 2023-09
PTC Therapeutics USD 1.22B 678.27M 2023-12
Regeneron Pharmaceuticals USD 24.49B 5.85B 2023-12
Revance Therapeutics USD 388.52M 9.57M 2023-09
Sarepta Therapeutics USD 2.45B 21.76M 2023-09
Teva Pharmaceutical Industries USD 11.42B 663M 2023-09
Vertex Pharmaceuticals USD 14.7B 822.9M 2023-09
Xencor USD 623.16M 51.98M 2023-12
Zoetis USD 6.34B 121M 2023-12



Coherus Biosciences Activos Circulantes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Mar 2024.